Lavino Francesco Maria

CIK 00017115172 companiesKING OF PRUSSIA, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001711517

Recent Transactions

26 trades

Tax Payment
Nabriva Therapeutics plc
Ordinary Shares
2020-09-30$0.53/sh−366→ 185,393 total
Tax Payment
Nabriva Therapeutics plc
Ordinary Shares
2020-08-31$0.62/sh−366→ 185,759 total
Tax Payment
Nabriva Therapeutics plc
Ordinary Shares
2020-08-20$0.65/sh−3,759→ 186,125 total
Exercise/Conversion
Nabriva Therapeutics plc
Restricted Share Units
2020-08-19−11,250→ 0 total
Exercise/Conversion
Nabriva Therapeutics plc
Ordinary Shares
2020-08-19+11,250→ 189,884 total
Tax Payment
Nabriva Therapeutics plc
Ordinary Shares
2020-07-31$0.76/sh−366→ 178,634 total
Tax Payment
Nabriva Therapeutics plc
Ordinary Shares
2020-06-30$0.67/sh−366→ 179,000 total
Tax Payment
Nabriva Therapeutics plc
Ordinary Shares
2020-05-31$1.14/sh−366→ 179,366 total
Tax Payment
Nabriva Therapeutics plc
Ordinary Shares
2020-04-30$0.55/sh−366→ 179,732 total
Tax Payment
Nabriva Therapeutics plc
Ordinary Shares
2020-03-31$0.57/sh−366→ 180,098 total
Tax Payment
Nabriva Therapeutics plc
Ordinary Shares
2020-02-28$1.35/sh−366→ 180,464 total
Award
Nabriva Therapeutics plc
Stock Options
2020-02-06+210,000→ 210,000 total
Award
Nabriva Therapeutics plc
Ordinary Shares
2020-02-06+105,000→ 180,830 total
Tax Payment
Nabriva Therapeutics plc
Ordinary Shares
2020-01-31$1.35/sh−3,892→ 75,830 total
Purchase
Nabriva Therapeutics plc
Ordinary Shares
2019-08-22$2.04/sh+4,800→ 15,972 total
Sale
Nabriva Therapeutics plc
Ordinary Shares
2019-08-21$2.08/sh−3,797→ 11,172 total
Tax Payment
Nabriva Therapeutics plc
Ordinary Shares
2019-08-21$2.08/sh−3,797→ 11,172 total
Exercise/Conversion
Nabriva Therapeutics plc
Restricted Share Units
2019-08-19−11,250→ 11,250 total
Exercise/Conversion
Nabriva Therapeutics plc
Ordinary Shares
2019-08-19+11,250→ 14,969 total
Award
Nabriva Therapeutics plc
Stock Options
2019-01-31+138,200→ 138,200 total
Award
Nabriva Therapeutics plc
Restricted Stock Units
2019-01-31+52,500→ 52,500 total
Purchase
Nabriva Therapeutics plc
Ordinary Shares
2018-05-23$4.60/sh+2,160→ 3,719 total
Award
Nabriva Therapeutics plc
Stock Options
2018-01-31+100,000→ 100,000 total
Award
Nabriva Therapeutics plc
Restricted Stock Units
2018-01-31+22,500→ 22,500 total
Purchase
Nabriva Therapeutics plc
Ordinary Shares
2017-11-29$6.29/sh+1,569→ 1,569 total
Award
Nabriva Therapeutics plc
Stock Option
2017-07-31+150,000→ 150,000 total

Companies

Recent Filings

Address

1000 CONTINENTAL DRIVE SUITE 600

KING OF PRUSSIA, PA, 19406

View on SEC.gov